Mark E. Spring serves as Executive at MEDIMMUNE INC /DE, where they oversee executive responsibilities. Since joining the company, Mark E. Spring has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 1, 2007 involved transacting 496 shares valued at $28.8K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 1, 2007 | MEDI | $28.8K | Tender | 496 | $58.00 | Discretionary |
Mark E. Spring currently holds 0 shares of MEDIMMUNE INC /DE (MEDI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark E. Spring has been a net neutral trader of MEDI stock. They have purchased $0 and sold $0 worth of shares.
Mark E. Spring's most recent insider trade was on Jun 1, 2007, when they sold 496 shares at $58.00 per share.
Get notified when new Form 4 filings are submitted